SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-022026
Filing Date
2023-05-01
Accepted
2023-05-01 16:05:36
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-05-01

Document Format Files

Seq Description Document Type Size
1 ARS ny20007987x4_ars.pdf ARS 548854
  Complete submission text file 0001140361-23-022026.txt   757319
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36829 | Film No.: 23873546
SIC: 2834 Pharmaceutical Preparations